- Home
- PSTL vs TMCI Comparison
PSTL vs TMCI Comparison
Compare PSTL & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTL
- TMCI
- Stock Information
- Founded
- PSTL 2018
- TMCI 2014
- Country
- PSTL United States
- TMCI United States
- Employees
- PSTL N/A
- TMCI N/A
- Industry
- PSTL Real Estate Investment Trusts
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PSTL Real Estate
- TMCI Health Care
- Exchange
- PSTL Nasdaq
- TMCI Nasdaq
- Market Cap
- PSTL 329.8M
- TMCI 390.6M
- IPO Year
- PSTL 2019
- TMCI 2021
- Fundamental
- Price
- PSTL $14.47
- TMCI $5.79
- Analyst Decision
- PSTL Strong Buy
- TMCI Hold
- Analyst Count
- PSTL 1
- TMCI 5
- Target Price
- PSTL $16.50
- TMCI $9.42
- AVG Volume (30 Days)
- PSTL 159.0K
- TMCI 267.8K
- Earning Date
- PSTL 08-05-2025
- TMCI 08-05-2025
- Dividend Yield
- PSTL 6.67%
- TMCI N/A
- EPS Growth
- PSTL 176.54
- TMCI N/A
- EPS
- PSTL 0.28
- TMCI N/A
- Revenue
- PSTL $81,235,000.00
- TMCI $210,819,000.00
- Revenue This Year
- PSTL $19.86
- TMCI $10.61
- Revenue Next Year
- PSTL $10.14
- TMCI $10.41
- P/E Ratio
- PSTL $51.42
- TMCI N/A
- Revenue Growth
- PSTL 23.36
- TMCI 7.54
- 52 Week Low
- PSTL $12.26
- TMCI $4.54
- 52 Week High
- PSTL $15.42
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- PSTL 44.39
- TMCI 45.97
- Support Level
- PSTL $14.42
- TMCI $5.60
- Resistance Level
- PSTL $14.85
- TMCI $6.11
- Average True Range (ATR)
- PSTL 0.25
- TMCI 0.25
- MACD
- PSTL -0.07
- TMCI 0.00
- Stochastic Oscillator
- PSTL 7.14
- TMCI 22.62
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.